Trades on 3 secondary markets

Curebase

Curebase is a San Francisco-based clinical trials technology company (founded 2017) that provides a modern, AI-native eClinical platform for sponsors, CROs, biotechs, MedTech companies, and research sites. The platform unifies the full trial lifecycle in one system: ePRO/eCOA (electronic patient-rep

emerging 21.8 / 100 0 APIs View provider profile →
CompanyHealthClinical TrialseClinicalLife SciencesHealthcare

Curebase is an API provider whose private shares are listed on 3 secondary markets: Hiive, EquityZen, Nasdaq Private Market.

Where It Trades

H Hiive View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.